NNC0519-0130
A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 Diabetes
Novo Nordisk · Phase 1 · Completed · Enrollment 82
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| NNC0519-0130 | Obesity + T2D | n/r | 37 | n/r | n/r |
| Placebo | Obesity + T2D | n/r | 37 | n/r | n/r |